S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
BREAKING: Tiny biotech successfully treats blindness (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
BREAKING: Tiny biotech successfully treats blindness (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
BREAKING: Tiny biotech successfully treats blindness (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
BREAKING: Tiny biotech successfully treats blindness (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
NYSE:HQL

Tekla Life Sciences Investors (HQL) Stock Forecast, Price & News

$13.22
+0.01 (+0.08%)
(As of 05/26/2023 ET)
Compare
Today's Range
$13.15
$13.29
50-Day Range
$13.21
$14.17
52-Week Range
$13.03
$16.33
Volume
62,581 shs
Average Volume
63,478 shs
Market Capitalization
$332.35 million
P/E Ratio
N/A
Dividend Yield
12.25%
Price Target
N/A

HQL stock logo

About Tekla Life Sciences Investors (NYSE:HQL) Stock

Tekla Life Sciences Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Stock News Headlines

⚡ 2,467% Return on Israeli Laser Company?
This advanced laser system is active in 80 countries around the world. And at the center of this massive market is a small firm in Israel. Our research shows that anyone who gets in today could see a return of 2,467%. But that's only if the company doesn't get taken over for a fast 300% gain first.
HQL Tekla Life Sciences Investors
Tekla Life Sciences: Dividend Insights
Tekla Life Sciences Investors (NYSE: HQL)
HQL: A Biotechnology Equity CEF With No Leverage
⚡ 2,467% Return on Israeli Laser Company?
This advanced laser system is active in 80 countries around the world. And at the center of this massive market is a small firm in Israel. Our research shows that anyone who gets in today could see a return of 2,467%. But that's only if the company doesn't get taken over for a fast 300% gain first.
Tekla Life Sciences cuts dividend by 10% to $0.35
5 Dividend Funds Yielding Up To 27.2%
Tekla Life Sciences Investors: 8% Yield, 7% Discount
Tekla Life Sciences Investors Declares Cash Distribution
Tekla Life Sciences Investors Declares Distribution
HQH: Deep Discount Leads To High Yield
HQL TeklaLife Sciences Investors Common Stock
Tekla Life Sciences declares $0.39 dividend
Tekla Life Sciences Investors Declares Stock Distribution
Top Picks 2020- Tekla Life Sciences Fund HQL
See More Headlines
Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Company Calendar

Ex-Dividend for 3/31 Dividend
2/24/2023
Dividend Payable
3/31/2023
Ex-Dividend for 6/30 Dividend
5/24/2023
Today
5/27/2023
Dividend Payable
6/30/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Investment offices, not elsewhere classified
Sub-Industry
N/A
Sector
Finance
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
22,615,000
Market Cap
$332.35 million
Optionable
Not Optionable
Beta
0.83

Key Executives

  • Dan Omstead
    President & Trustee
  • Jason C. Akus
    Senior Vice President-Research
  • Laura F. Woodward
    Secretary, Treasurer & Chief Compliance Officer
  • Timothy L. Gasperoni
    Senior Vice President-Research













HQL Stock - Frequently Asked Questions

How have HQL shares performed in 2023?

Tekla Life Sciences Investors' stock was trading at $14.21 on January 1st, 2023. Since then, HQL shares have decreased by 7.0% and is now trading at $13.22.
View the best growth stocks for 2023 here
.

Are investors shorting Tekla Life Sciences Investors?

Tekla Life Sciences Investors saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 39,800 shares, a drop of 27.2% from the April 30th total of 54,700 shares. Based on an average trading volume of 75,500 shares, the short-interest ratio is presently 0.5 days.
View Tekla Life Sciences Investors' Short Interest
.

How often does Tekla Life Sciences Investors pay dividends? What is the dividend yield for Tekla Life Sciences Investors?

Tekla Life Sciences Investors declared a quarterly dividend on Tuesday, May 16th. Investors of record on Thursday, May 25th will be given a dividend of $0.32 per share on Friday, June 30th. This represents a $1.28 dividend on an annualized basis and a yield of 9.68%. The ex-dividend date of this dividend is Wednesday, May 24th.
Read our dividend analysis for HQL
.

What ETFs hold Tekla Life Sciences Investors' stock?

ETFs with the largest weight of Tekla Life Sciences Investors (NYSE:HQL) stock in their portfolio include First Trust Income Opportunities ETF (FCEF),

Is Tekla Life Sciences Investors a good dividend stock?

Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.62 per share and currently has a dividend yield of 12.26%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for HQL.

What other stocks do shareholders of Tekla Life Sciences Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY).

What is Tekla Life Sciences Investors' stock symbol?

Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL."

Who are Tekla Life Sciences Investors' major shareholders?

Tekla Life Sciences Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James & Associates (1.23%), Wolverine Asset Management LLC (1.22%), Allspring Global Investments Holdings LLC (0.87%), LPL Financial LLC (0.67%), Ameriprise Financial Inc. (0.54%) and 180 Wealth Advisors LLC (0.44%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead and Kathleen Goetz.
View institutional ownership trends
.

How do I buy shares of Tekla Life Sciences Investors?

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tekla Life Sciences Investors' stock price today?

One share of HQL stock can currently be purchased for approximately $13.22.

How much money does Tekla Life Sciences Investors make?

Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $332.35 million.

How can I contact Tekla Life Sciences Investors?

Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577.

This page (NYSE:HQL) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -